US Compounding Recalls LET Gel 4% Syringes Due to Missing Lot and Expiration Dates
US Compounding Inc is recalling 1,931 syringes of LET Gel 4% because the labels are missing specific lot and expiration dates.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, but the specific hazard is a labeling error (missing lot and expiration dates) without reported injuries or illnesses, fitting the 'Moderate' criteria for minor labeling errors.
Plain-English summary
US Compounding Inc is recalling 1,931 syringes of LET Gel 4% (Lidocaine HCl 4% + EPINEPHrine HCl 0.05% + Tetracaine HCl 0.5%), 3mL Single Use Syringe. The product is prescription-only and was distributed nationwide in the USA.
The recall was initiated due to labeling errors where the labels are missing the specific lot and expiration date. Instead, the labels are printed with placeholder text: Lot# YYYDDYY@XX and Beyond Use Date: MM/DD/YYYY.
Consumers and healthcare providers should stop using the affected syringes and contact US Compounding Inc at 800-718-3588 for instructions on how to return the product.
The recalled product
- Product
- LET Gel 4% (Lidocaine HCl 4% + EPINEPHrine HCl 0.05% + Tetracaine HCl 0.5%), 3mL Single Use Syringe, Rx only, US Compounding, 1270 Don's Lane, Conway, AR, 800-718-3588, Barcode 62295501303.
- Manufacturer
- US Compounding Inc
- Category
- Drug — Topical Anesthetic
- Hazard
- Affected units
- 1,931
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Labeled as Lot# YYYDDYY@XX
- Beyond Use Date: MM/DD/YYYY.
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · US Compounding Inc
See all →- LowUS Compounding Recalls Succinylcholine Chloride Injection Due to Labeling Error
FDA (Drugs) · 2021-01-20
- LowUS Compounding Recalls Neostigmine Methylsulfate Syringes Due to Missing Labels
FDA (Drugs) · 2021-01-06
- SevereUS Compounding Recalls Ephedrine Sulfate Syringes Due to Sterility Concerns
FDA (Drugs) · 2019-02-27
- SevereUS Compounding Recalls Docusate Oral Syringes Due to B. cepacia Contamination
FDA (Drugs) · 2016-12-28
- SevereUS Compounding Recalls Choline Chloride Inositol Cyanocobalamin Injection Vials
FDA (Drugs) · 2015-11-25
Same hazard · mis labeling
See all →- SevereImperio Distribution Recalls Beef Jerky Produced Without Federal Inspection
USDA FSIS · 2026-10-24
- HighJ K Patisserie Chocolate Chip Cookies Recalled for Undeclared Soy
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- LowMindray ePM Series Patient Monitor Manuals Recalled for Alarm Clarification
FDA (Devices) · 2026-10-14
Similar recalls
- SevereUS Compounding Recalls Lidocaine Syringes Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-11-25
- SevereUS Compounding Recalls Hyaluronic Acid Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-11-25
- LowUS Compounding Recalls Neostigmine Methylsulfate Syringes Due to Missing Labels
FDA (Drugs) · 2021-01-06
- LowUS Compounding Recalls Succinylcholine Chloride Injection Due to Labeling Error
FDA (Drugs) · 2021-01-20
- SevereUS Compounding Recalls Succinylcholine Chloride Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-11-25
- ModerateUS Compounding Recalls Mislabeled Ephedrine Sulfate Injection Syringes
FDA (Drugs) · 2014-08-27